SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

FDC - Quaterly Results

14 Nov 2022 Evaluate
The September 2022 quarter revenue stood at Rs. 4462.21 millions, up 12.60% as compared to Rs. 3962.85 millions during the corresponding quarter last year.Net Profit of the company move down -30.29% to Rs. 512.76  millions from Rs. 735.51 millions  in the same quarter last year.Operating profit for the quarter ended September 2022 decreased to 797.60 millions as compared to 1027.19 millions of corresponding quarter ended September 2021.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 4462.21 3962.85 12.60 9392.29 8412.47 11.65 15189.65 13254.49 14.60
Other Income 286.31 305.76 -6.36 480.30 540.10 -11.07 787.34 971.46 -18.95
PBIDT 797.60 1027.19 -22.35 1791.78 2401.95 -25.40 3255.80 4214.76 -22.75
Interest 10.11 7.17 41.00 17.07 15.17 12.52 30.48 34.02 -10.41
PBDT 787.49 1020.02 -22.80 1774.71 2386.78 -25.64 3225.32 4180.74 -22.85
Depreciation 99.38 94.36 5.32 192.55 189.31 1.71 370.81 376.23 -1.44
PBT 688.11 925.66 -25.66 1582.16 2197.47 -28.00 2854.51 3804.51 -24.97
TAX 175.35 190.15 -7.78 339.21 460.87 -26.40 658.15 859.61 -23.44
Deferred Tax -7.65 0.15 -5200.00 -86.79 -40.13 116.27 -21.85 14.45 -251.21
PAT 512.76 735.51 -30.29 1242.95 1736.60 -28.43 2196.36 2944.90 -25.42
Equity 165.91 168.81 -1.72 165.91 168.81 -1.72 168.81 168.81 0.00
PBIDTM(%) 17.87 25.92 -31.04 19.08 28.55 -33.19 21.43 31.80 -32.59

FDC Share Price

358.65 2.60 (0.73%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×